Evidence map›Paper›PMID 34644459›Full record

ArticlePediatric pulmonology2022

Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm?

Emma Binns, Marianne Koenraads, Lidia Hristeva, Alix Flamant, Sebastian Baier-Grabner, Mervin Loi, Johanna Lempainen, Elise Osterheld, Bazlin Ramly, Jessica Chakakala-Chaziya and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric pulmonology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 13 institutions in 13 countries.

Emma BinnsDepartment of Paediatrics, Christchurch Hospital, Christchurch, New Zealand.
Marianne KoenraadsAlder Hey Children's Hospital, Liverpool, UK.
Lidia HristevaGeneral Paediatrics/Neonates, London, UK.
Alix FlamantCliniques Universitaires Saint-Luc, Brussels, Belgium.
Sebastian Baier-GrabnerDepartment of Paediatrics and Adolescent Medicine, Klinik Ottakring, Vienna Healthcare Group, Vienna, Austria.
Mervin LoiChildren's Intensive Care Unit, KK Women's and Children's Hospital, Singapore, Singapore.
Johanna LempainenDepartment of Paediatrics, Institute of Biomedicine and Clinical Microbiology, University of Turku and Turku University Hospital, Turku, Finland.
Elise OsterheldDepartment of Paediatrics, Centre Hospitalier de Mayotte, Mayotte, France.
Bazlin RamlyPaediatric Department, Children Health Ireland, Dublin, Ireland.
Jessica Chakakala-ChaziyaPaediatric Department, Muzu Central Hospital, Ministry of Health, Muzu, Malawi.
Niveditha EnaganthiPaediatric Department, Sri Ramachandra Medical College & RI, Chennai, Tamil Nadu, India.
Silvia Simó NebotInfectious Diseases and Systemic Inflammatory Response in Paediatrics, Infectious Diseases Unit, Sant Joan de Déu Hospital Research Foundation, Barcelona, Spain.
Danilo BuonsensoDepartment of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.ORCID 0000-0001-8567-2639
Children's Health Ireland at Crumlin · IEChristchurch Hospital · NZCliniques Universitaires Saint-Luc · BEGeneral Electric (United Kingdom) · GBIstanbul 29 Mayis University · TRKK Women's and Children's Hospital · SGMedical University of Vienna · ATMzuzu University · MWSant Joan de Déu Research Foundation · ESSri Ramachandra Institute of Higher Education and Research · INUniversità Cattolica del Sacro Cuore · ITUniversity of Liverpool · GBUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal epidemics of influenza and the respiratory syncytial virus (RSV) are the cause of substantial morbidity and mortality among children. During the global coronavirus disease 2019 (COVID-19) pandemic, the epidemiology of these viruses seems to have changed dramatically. In Australia and New Zealand, a significant decrease in both influenza and bronchiolitis have been noticed during usual peak seasons. Data from early months of winter seasons in Europe are showing similar trends. This current scenario imposes a reconsideration of the paradigm that toddlers and young schoolchildren are the main drivers of seasonal RSV outbreaks and respiratory epidemics in general. In this article, we summarize current literature, address current knowledge or role of adults in the RSV epidemiology, describe the lessons learned from pertussis epidemics and call the international community to better understand the community transmission dynamics of respiratory infections in all age groups. This can allow the establishment of better and more affordable preventive measures in the whole population level, which can ultimately save millions of child lives.

Indexed as

COVID-19Influenza, HumanRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsAdultChildHumansPandemicsSARS-CoV-2COVID-19influenzarespiratory syncytial virusSARS-COV-2

Identifiers

PMID34644459
PMCPMC8662286
OpenAlexW3169327070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.